Viridian Therapeutics, Inc.\de
Ticker: VRDN
| Insider | Title |
|---|---|
| Arlene Morris | Director |
| Barrett Katz | Chief Medical Officer |
| Carrie Melvin | COO |
| Funds Management Llc Fairmount | Director, 10% or greater ownership |
| Healthcare Fund Gp Llc Fairmount | Director |
| Healthcare Fund Ii Gp Llc Fairmount | Director, 10% or greater ownership |
| Healthcare Fund Ii L.p. Fairmount | Director, 10% or greater ownership |
| Healthcare Fund L.p. Fairmount | Director |
| Jennifer K. Moses | Director |
| Jennifer Tousignant | Chief Legal Officer |
| Jonathan Violin | Chief Executive Officer, Director |
| Kristian Humer | CFO and CBO |
| L.l.c. Fhmlsp, | 10% or greater ownership |
| L.p. Fhmlsp, | 10% or greater ownership |
| Lara Meisner | General Counsel and Secretary |
| Life Sciences Public Fund, L.p. Frazier | 10% or greater ownership |
| Peter Evan Harwin | Director |
| Sarah Gheuens | Director |
| Scott Dunseth Myers | Chief Executive Officer, Director |
| Stephen F. Mahoney | President and CEO, Director |
| Thomas Ciulla | Chief Medical Officer |
| Thomas W. Beetham | Chief Operating Officer |
| Tomas Kiselak | Director |